Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/06/23 → 8/06/25 |
Keywords
- clinical trial
- Alzheimer’s Disease
- Aducanumab
A Phase 3b/4 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants with Alzheimer’s Disease
- Darby, David (Primary Chief Investigator (PCI))
Project: Research